4 results

Jim Chanos, founder and president of Kynikos Associates, speaks at the Skybridge Alternatives conference in Las Vegas, where he said he was shorting Irish drug company Mallinckrodt. Photographer: David Paul Morris/Bloomberg

Investment manager Jim Chanos is shorting Irish drugmaker Mallinckrodt and US pharmacy-benefit manager Express Scripts Holding as scrutiny increases o(...)

 Irish-based pharmaceutical firm Mallinckrodt said it is pleased to confirm that it has entered a settlement agreement with the US Federal Trade Commission. Photograph:

Irish-based pharmaceutical firm Mallinckrodt agreed to pay $100 million (€93.8 million) to settle claims that its US unit illegally boosted the price (...)

About 2.2 million CRH shares changed hands in Dublin yesterday, slightly more than usual. Photograph: Alan Betson

Tumbling technology share helped trigger the biggest decline in European markets in a month yesterday. Traders in Dublin said w(...)

Mallinckrodt was spun-off by Covidien last year, and has an Irish plant in Mulhuddart, Dublin 15.

Dublin-domiciled specialty pharmaceuticals company Mallinckrodt has agreed to buy Questcor Pharmaceuticals for $5.6 billion (€4bn) in cash and stoc(...)